Search

Your search keyword '"Divyaveer, Smita"' showing total 153 results

Search Constraints

Start Over You searched for: Author "Divyaveer, Smita" Remove constraint Author: "Divyaveer, Smita"
153 results on '"Divyaveer, Smita"'

Search Results

1. Capacity for the management of kidney failure in the International Society of Nephrology South Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).

3. Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF – An Open Label Randomized Clinical Trial

4. WCN24-668 ROLE OF COAGULATION FACTORS IN BLEEDING AND THROMBOTIC EVENTS IN CKD AND THEIR CORRELATION WITH CONVENTIONAL AND SONOCLOT PARAMETERS IN HAEMODIALYSIS PATIENTS

5. WCN24-1597 A PROSPECTIVE STUDY TO ANALYSE THE ACCURACY OF ESTIMATED GFR EQUATIONS AS COMPARED TO MEASURED GFR BY IOHEXOL CLEARANCE IN PATIENTS WITH LIVER CIRRHOSIS

6. WCN24-968 COMPARISON OF ESTIMATED AND MEASURED GFR IN INDIAN CIRRHOTIC PATIENTS:- A CASE SERIES

7. WCN24-1579 TO COMPARE ACCURACY OF SERUM VS. URINE BIOMARKERS IN PREDICTING AKI AND MAJOR ADVERSE KIDNEY EVENTS AT DAY 30 IN CRITICALLY ILL CIRRHOTIC PATIENTS

8. WCN24-1323 TO DETERMINE THE EFFICACY OF LACTOFERRIN IN IMPROVING HEMOGLOBIN LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS WITH IRON DEFICIENCY ANEMIA

9. WCN24-1211 To determine the effectiveness of Lactoferrin in improving Anemia in iron replete CKD patients

11. WCN24-1274 THE EFFECT OF LACTOFERRIN ON HEMOGLOBIN, ERYTHROFERRONE AND HEPCIDIN LEVELS IN CHRONIC KIDNEY DISEASE

13. Clinical Characteristics and Outcomes of Neural Epidermal Growth Factor-like 1 Protein-Associated Membranous Nephropathy

14. Effectiveness of Lactoferrin in the Treatment of Anemia in Chronic Kidney Disease: A Single-Center Pilot Study.

15. Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography.

16. Effectiveness of Lactoferrin in the Treatment of Anemia in Chronic Kidney Disease: A Single-Center Pilot Study

17. Capacity for the management of kidney failure in the International Society of Nephrology North and East Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

18. Capacity for the management of kidney failure in the International Society of Nephrology Middle East region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

19. Capacity for the management of kidney failure in the International Society of Nephrology Eastern and Central Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

20. Capacity for the management of kidney failure in the International Society of Nephrology Western Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

21. Capacity for the management of kidney failure in the International Society of Nephrology Newly Independent States and Russia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

22. Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

23. Capacity for the management of kidney failure in the International Society of Nephrology Africa region: report from the 2023 ISN Global Kidney Atlas (ISN-GKHA)

24. Capacity for the management of kidney failure in the International Society of Nephrology North America and the Caribbean region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

25. Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

26. ABO-Incompatible Renal Transplant: A Single-Center Experience from India.

27. Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk

30. Cirrhotic cardiomyopathy influences clinical outcomes and enhances performance of conventional risk prediction models in acute‐on‐chronic liver failure with severe sepsis.

31. Complementary medicine and phospholipase A2 receptor (PLA2R)–related membranous nephropathy—fortuitous or causal?

33. Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding

35. Intravenous branched chain amino acid infusion is associated with early but ill-sustained recovery of overt hepatic encephalopathy in acute-on-chronic liver failure: a pilot protocol

36. Role of hepcidin, altered iron metabolism and systemic inflammation in the pathogenesis of iron deficiency anemia, anemia of chronic disease, and iron refractory anemia in cirrhosis and ACLF.

37. Assessment of dynamic cardiac function, fluid resuscitation targets, cardiac biomarkers and predictors of survival in acute-on-chronic liver failure with severe sepsis or septic shock

39. S3403 Assessment of Role of Iron Metabolism, Vitamin Deficiency, Gastrointestinal Blood Loss, and Chronic Inflammation in the Etiopathogenesis of Anemia in Chronic Liver Disease

40. Serum catalytic iron and progression of chronic kidney disease: findings from the ICKD study.

42. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in South Asia

46. Hypervitaminosis D and acute interstitial nephritis: Tale of injections

50. Immunoadsorption column reuse

Catalog

Books, media, physical & digital resources